INTRODUCTION
Urinary incontinence affects from 15% to 50% of community-dwelling women of all ages. It is one of the most prevalent chronic diseases, although it is often not recognized by the US healthcare system. The direct cost of urinary incontinence for women in the United States was $12.4 billion in 1995 dollars (1) . Approximately one in ten women in the United States undergoes surgery for urinary incontinence or pelvic organ prolapse, and a sizable minority of women bear the cost of pads, medications, and nonsurgical therapies.
Population-based studies estimate that a large proportion of adult women report the symptom of urinary incontinence. As many as three-fourths of US women report at least some urinary leakage and studies consistently find that 20 to 50% report more-frequent leakage. While some authors have interpreted this to mean that nearly half of American women "suffer" from incontinence, others point out that many women with occasional incontinence are not sufficiently bothered by it to seek care. Of greater clinical relevance is an improved understanding of the number of women with severe or more-frequent leakage, estimated fairly uniformly at 7% to 10% by various researchers. Currently, there is little understanding of the number of women whose lives are truly impacted by urinary incontinence or of its true burden on American women. Indeed, the demarcation between incontinence as a symptom and incontinence as a disease is far from clear. For example, 25% of female college varsity athletes lose urine when doing provocative exercise, and most do not consider it a problem; indeed, most experts would agree that these young women do not have a major health problem. Conversely, most experts would agree that middle-aged women who lose urine throughout the day, wear pads, curtail desired activities because of leakage, and truly suffer have a disease and would benefit from treatment.
Studies that inquire about the presence of "any" or "occasional" incontinence may overestimate the actual burden of incontinence on the healthcare system, but available data on incontinence treatment underestimate the actual burden, given that many women with bothersome leakage do not seek care. While readily available information about incontinence treatment in adult women in the United States indicates only the lowest possible burden urinary incontinence presents to the healthcare system, it does provide a foundation on which to base future studies and to project future care. This chapter uses data from various sources to begin defining not only the prevalence of incontinence, but also its impact on the US healthcare system. At this time, equally important information about the burden of disease on women who are not seeking treatment is not available. The impact of incontinence on the women themselves, their families, their work, and society is also not yet well defined in the literature. any involuntary leakage of urine" (2) . This supplants the group's previous long-held definition, in which the diagnosis of incontinence required that the leakage be a social or hygienic problem. The less restrictive definition is likely to capture more individuals who experience incontinence, including the many women who may leak daily but do not describe leakage as a social or hygienic problem. A diagnosis of urinary incontinence can be based on the patient's symptoms, the sign of incontinence noted during physical examination, or diagnostic urodynamic testing. Table  1 lists ICD-9 codes commonly used to identify urinary incontinence. The International Continence Society further categorizes types of incontinence, as well as other bladder symptoms. Stress urinary incontinence is the complaint of involuntary leakage on effort or exertion or on sneezing or coughing. Stress urinary incontinence also describes the sign, or observation, of leakage from the urethra synchronous with coughing or exertion. When stress incontinence is confirmed during urodynamic testing by identifying leakage from the urethra coincident with increased abdominal pressure (for example, during a cough or sneeze) but in the absence of a bladder contraction, the diagnosis of urodynamic stress incontinence is made.
DEFINITION AND DIAGNOSIS

Urinary incontinence is defined by the
Urge urinary incontinence is the complaint of involuntary leakage accompanied by or immediately preceded by an urge to urinate and may be further defined with urodynamic investigation. Conventional urodynamic studies take place in a laboratory and involve filling the bladder with a liquid, then assessing bladder function during filling and emptying. If during urodynamic testing the patient demonstrates either spontaneous or provoked involuntary detrusor contractions while filling, she is said to have detrusor overactivity. If a relevant neurologic condition exists, the detrusor overactivity is further categorized as neurogenic; when no such condition is identified, the overactivity is termed idiopathic. These terms replace the previously used detrusor hyperreflexia and detrusor instability. Many women with urge incontinence do not manifest detrusor overactivity on urodynamic testing. This may be due in part to the fact that such testing, which lasts approximately an hour, is merely a snapshot of the patient's overall bladder function. Ambulatory urodynamic studies can also be performed to document the patient's leakage during everyday activities; such studies identify more detrusor contractions during filling than do conventional ones. Nonetheless, treatment for urge incontinence is often based on implicit clinical assessment because of the low predictive value of a negative test.
Other diagnostic tests may be used to help characterize incontinence and its severity. A pad test quantifies the volume of urine lost by weighing a perineal pad before and after some type of leakage provocation. This type of test has also been used in attempts to distinguish continent from incontinent women. Pad tests can be divided into short-term tests, usually performed under standardized office conditions, and long-term tests, usually performed at home for 24 to 48 hours. Short-term pad tests are generally performed with a symptomatically full bladder or with a certain volume of saline instilled into the bladder before the patient begins a series of exercises.
A voiding diary, or bladder chart, is a record maintained by the patient of her urinary frequency and leakage, voided volumes, and fluid intake over a 3-to 7-day period. This noninvasive test provides useful information about bladder capacity, type of incontinence symptoms, diurnal versus nocturnal voiding patterns, and appropriateness of fluid intake.
PREVALENCE AND INCIDENCE
As noted above, a wide range in the prevalence of urinary incontinence has been reported. One compilation of such studies (3) indicates that approximately 50% of adults report "any" incontinence, while 5% to 25% note leakage at least weekly, and 5 to 15% note it daily or most of the time ( Table 2) . Rates of incontinence severity patterns are depicted in Figure 1 . The rate of urge incontinence tends to rise with age, while the rate of stress incontinence decreases somewhat in the oldest age groups, possibly due to lower activity levels ( Figure 2) . In a large population of Norwegian women, the rate of stress incontinence peaked at approximately 60% in women 40 to 49 years of age; urge incontinence began to rise in women 50 to 59 years of age and peaked at roughly 20% in women between 80 and 89 years of age (4) . Reasons for the divergence of estimates include variations in definitions, sampling methodologies, response rates, and question formats (5). Follow-ups III and IV include responses 3 and 6 years after baseline, respectively.
SOURCE:
Adapted from Nygaard IE, Lemke JH, Urinary incontinence in rural older women: prevalence, incidence, and remission, Journal of American Geriatrics Society, 44, 1,049-1,054, Copyright 1996, with permission from the American Geriatrics Society. Prevalence of incontinence by age groups at baseline.
Each age represents the midpoint of a 3-year age range. Because of the small number of women above age 90, the graph ends with age range 86-88. "Urge" and "stress" refer to women who answered affirmatively to the urge and stress incontinence questions, respectively. "Either" refers to women who reported any incontinence (either urge or stress).
Adapted from Nygaard IE, Lemke JH, Urinary incontinence in rural older women: prevalence, incidence, and remission, Journal of American Geriatrics Society, 44, 1,049-1,054, Copyright 1996, with permission from the American Geriatrics Society. Consistent with the Norwegian study, the National Health and Nutrition Examination Survey (NHANES) asked a national sample of communitydwelling adults, "In the past 12 months, have you had difficulty controlling your bladder, including leaking small amounts of urine when you cough or sneeze (exclusive of pregnancy or recovery from childbirth)?" NHANES found the overall prevalence of urinary incontinence in women, as defined in this question, to be 38% in [1999] [2000] (Table 3 ). When broken down by frequency of episodes, 13.7% of all women in NHANES reported daily incontinence, and an additional 10.3% reported weekly incontinence (Table 4) . Prevalence was higher in non-Hispanic whites (41%) than in non-Hispanic blacks (20%) or Mexican Americans (36%). The prevalence of daily incontinence increased with age, ranging from 12.2% in all women 60 to 64 years of age to 20.9% in those 85 years of age and over ( Figure 3 ). Women with less than a high school education reported incontinence less often than did those with at least a high school education.
Other large population-based studies have also reported higher rates of urinary incontinence among non-Hispanic whites than in other ethnic or racial groups. In a large cohort of 50-to 69-year- old women enrolled in the Health and Retirement Survey, non-Hispanic blacks and Hispanics were both 60% less likely to have severe incontinence than were non-Hispanic whites, after adjusting for various comorbidities (6) . Similarly, baseline data from the Heart and Estrogen/Progestin Replacement Study showed that non-Hispanic whites were 2.8 times more likely to have weekly stress incontinence than were non-Hispanic blacks, after adjusting for relevant factors (7) . This epidemiologic trend appears consistent with laboratory findings as well. Graham and colleagues noted that among women presenting for incontinence treatment, stress incontinence was diagnosed more frequently in Caucasian women, and detrusor overactivity was seen more often in African American women (8) . These diagnoses were also consistent with the study's finding that Caucasian women had lower urethral closure pressures than did African American women, while African American women had a lower bladder capacity than Caucasian women (Table 5) . A recent analysis of data from the Study of Women's Health Across the Nation (SWAN), which included 3,302 women 42 to 52 years of age provided a closer look at nuances related to race/ethnicity and urinary incontinence (9) . African American women with leiomyomata had a 1.81-fold higher risk of urinary incontinence than did Caucasian women, while African American women without fibroids had a decreased risk of urinary incontinence (OR 0.31). Hispanic and Japanese women had a lower risk than did Caucasian women (OR 0.44 and 0.58, respectively). In Chinese women, the risk of incontinence was modified by educational status; the OR of those with less than a college education was 0.35 relative to that of Caucasian women, and 2.53 for those with at least a college education. Data from the Veterans Health Affairs (VA) were used to estimate the utilization of outpatient care for urinary incontinence among female veterans accessing VA health services. Of all women who received outpatient care in the VA system, urinary incontinence as a percentage of any diagnosis was 2.7% in 1999, 3.6% in 2000, and 3.8% in 2001 (Table  6 ). These proportions are substantially lower than the rates of daily incontinence reported in populationbased surveys, suggesting that the majority of women with incontinence do not seek medical care for it. As expected, the prevalence of medically recognized urinary incontinence increased with age, with the most marked increase occurring between the 25-to 34-year-olds and the 45-to 54-year-olds. Incontinence was more than twice as common among nonHispanic whites as it was among African Americans and approximately 50% more common among nonHispanic whites than among Hispanics. Incontinence was most common in the Western region of the United States and least common in the Eastern region, except in 2001, although these differences were not adjusted for differences in age or race/ethnicity.
Less is known about incontinence incidence, remission, and natural history. In prospective cohort studies using a survey design, 10% to 20% of women report remission or recurrence of incontinence over a 1-to 2-year-period (10) . Whether this reflects the natural history of incontinence, active intervention, or decreased physical activity (relevant to stress incontinence) is not clear. 
RISK FACTORS
Most data on risk factors for urinary incontinence come from clinical trials or cross-sectional studies using survey designs. Some risk factors have been more rigorously studied than others. Hence, the available information has limited generalizability and causality cannot be inferred from it. Bearing these limitations in mind, the literature does suggest that age, pregnancy, childbirth, obesity, functional impairment, and cognitive impairment are associated with increased rates of incontinence or incontinence severity. Some factors pertain more to certain age groups than to others. For example, in older women, childbirth disappears as a significant risk factor, possibly due to increased comorbidities and other intervening factors, such as diabetes, stroke, and spinal cord injury. Other factors about which less is known or findings are contradictory include hysterectomy, constipation, occupational stressors, smoking, and genetics.
TREATMENT
Fewer than half of the women with urinary incontinence report seeking medical care (11). Johnson and colleagues (12) found that the incontinent people most likely to contact a medical doctor are those who use pads, those who have large volume accidents, those who have impairment in activities of daily living; also, men are more likely to seek medical care than women are (Table 7) . Many incontinent people practice behavioral modifications such as limiting trips, fluids, and routine activities. These restrictions are particularly striking in women with concomitant fecal incontinence (Table 8) .
Most treatment for urge incontinence is nonsurgical. Common therapeutic modalities include pharmacologic treatment, physiotherapy, biofeedback, 95% confidence intervals for age and gender may include 1.0 for odds ratio. In the case of bivariate analysis, the criterion was to include variables significant at α = 0.10.
For multivariate analysis, age and gender variables were forced into all final models because they were the stratification variables of the sample. SOURCE: Reprinted from Johnson TM, Kincade JE, Bernard SL, Busby-Whitehead J, DeFriese GH, Self-care practices used by older men and women to manage urinary incontinence: Results from the national follow-up survey on self-care and aging, Journal of the American Geriatrics Society, 48, 894-902, Copyright 2000, with permission from the American Geriatrics Society. bladder retraining, and electrical stimulation. For women with intractable, severe urge incontinence, direct neuromodulation of the sacral spinal cord is an increasingly popular option. Surgical therapy designed to increase bladder capacity and decrease contractility is rarely used. In contrast, surgery is a mainstay of therapy for stress urinary incontinence. Surgeries performed frequently for stress incontinence in the past -anterior colporrhaphies and needle suspension procedureshave more recently been supplanted by retropubic urethropexies, pubovaginal slings (using various types of sling materials), and collagen injections. Based on available evidence that the long-term (3 to 5 years) success rate of anterior colporrhaphy and needle suspension procedures is significantly lower than that of the other two procedures, the Agency for Healthcare Research and Quality (AHRQ), (13) and the American Urological Association (14) have both taken the position that retropubic urethropexies and pubovaginal slings are the procedures of choice for stress incontinence. This trend is seen clearly in a study describing the trends in surgical management by American urologists between 1995 and 1999 (15) (Figure 4) .
Nonsurgical therapies are also prominent in the treatment of women with stress urinary incontinence. The primary modality used is pelvic muscle rehabilitation ("Kegel exercises").
Vaginal and urethral devices, bladder training, and biofeedback are also frequently used. In the near future, new pharmacologic agents will be available as well. While nonsurgical therapies for urge and stress urinary incontinence render only a minority of women completely dry, more than half of the women who participate in trials that assess such therapies report at least a 50% improvement in incontinence episodes. There is Level 1 evidence to support the use of pelvic muscle rehabilitation, bladder training, and anticholinergic therapy in women with some types of urinary incontinence. However, the literature on large, well-designed trials that are generalizable to the population seeking care is limited. Data are lacking on the long-term follow-up of nonsurgical treatment.
TRENDS IN HEALTHCARE RESOURCE UTILIZATION
Inpatient Care
Surgical Treatment
Surgical treatment for urinary incontinence can be more easily tracked in existing databases than can non-surgical management. Surgical therapy accounts for a considerable proportion of the cost related to incontinence. Although only a small fraction of all women with urinary incontinence seek surgical intervention, the number of women treated with surgery is substantial. Using a large managed-care database, Olsen and colleagues (1997) reported an 11.1% lifetime risk of undergoing a single operation for urinary incontinence or pelvic organ prolapse by age 80 (Table 9 ) (16) . Using data from the 1998 National Hospital Discharge Survey and the 1998 National Census, Waetjen and colleagues (2003) calculated that approximately 135,000 women in the United States had inpatient surgery for stress urinary incontinence in 1998 (17) .
Data from the Healthcare Cost and Utilization Project (HCUP) indicate that the annual rate of hospitalizations for a primary diagnosis of urinary incontinence remained stable at 51 to 54 per 100,000 between 1994 and 1998, then dropped to 44 per 100,000 in 2000 (Table 10 ). It is unclear whether this drop reflects an actual trend, potentially attributable to newer ambulatory surgical techniques. The annual rate of hospitalizations was higher for women 45 to 84 years of age, peaking in the 65 to 74 age group at 108 per 100,000 ( Figure 5 ). Hospitalizations were most common in women residing in the South and West and least common in women living in the Northeast. Women living in urban areas had a higher rate of hospitalizations than did those in rural areas. Most of the hospitalizations for urinary incontinence were probably for surgical treatments. The number of hospitalizations in Table 10 represents roughly one-half of the number of incontinence procedures reported by Waetjen, et. al. This is most likely due to the fact that Waetjen included inpatient stays in which the primary diagnosis was gynecological (such as pelvis organ prolapse) and in whom an incontinence procedure was done in concert with other procedures to repair the primary gynecological problem. Future analyses will address this issue. Similar trends for older women were found in Medicare (Table 11 ) and HCUP (Table 10 ). The rate of inpatient stays for urinary incontinence for older women enrolled in Medicare (those 65+) ranged from 86 to 99 per 100,000 annually, with women between 65 and 74 more likely than the other age groups to be hospitalized.
Geographic and racial/ethnic distributions were similar to those found in HCUP and significant differences among racial/ethnic groups were also noted.
Among women with commercial health insurance, the rate of inpatient hospitalizations for incontinence procedures (primary or any procedure) ranged from 123 per 100,000 women in 1994 to 114 per 100,000 in 2000 (Table 12 ). Most of these procedures were performed in conjunction with other surgical procedures and are thus listed as any procedure. Hospitalizations for incontinence surgeries as primary procedures ranged from 59 per 100,000 women in 1994 to 33 per 100,000 in 2000. These data suggest a trend toward decreasing numbers of inpatient surgeries for incontinence; if this trend is substantiated in future years, it may reflect either the increased emphasis on nonsurgical treatment for urinary incontinence that followed the dissemination of the AHRQ guidelines or increased utilization of ambulatory incontinence surgeries. Consistent with decreasing lengths of inpatient stay for other conditions during the past decade, length of stay for women with urinary incontinence as their primary discharge diagnosis decreased steadily, from 3.1 days in 1994 to 2.1 days in 2000 (Table 13 ). Women in the oldest age groups were hospitalized longer than were those younger than 75. For example, in 2000, length of stay remained stable at 2.1 days in women between 18 and 74 years of age, and varied from 2.7 to 2.9 days in women older than 75. Length of stay was similar across racial/ethnic groups and regions of the country.
Surgical Procedures
In 1998, the most commonly performed surgical procedures for female urinary incontinence were collagen injections, pubovaginal slings, and anterior urethropexies (Table 14) . Because anterior colporrhaphies may be performed for either urinary incontinence (a condition for which they are not a currently recommended treatment) or anterior pelvic organ prolapse (cystocele), rates for this procedure are not described. A striking decrease was seen in both Raz and Peyrera needle suspension procedures between 1992 and 1998: Raz procedures decreased from 4,364 per 100,000 women in 1992 to 1,564 per 100,000 in 1998, while Peyrera procedures were done too infrequently by 1998 to be detected in the data. Concomitantly, pubovaginal slings increased from 621 per 100,000 women in 1995 to 2,776 per 100,000 in 1998. The number of women undergoing anterior urethropexy decreased, though less dramatically, from 3,941 per 100,000 women in 1992 to 2,364 per 100,000 in 1998.
Despite an increase in cesarean deliveries and complex laparoscopic pelvic surgeries (two major sources of urogenital fistulae) during the time frame studied, national hospitalization data showed no Persons of other races and missing or unavailable race and ethnicity are included in the totals. NOTE: Counts may not sum to totals due to rounding. SOURCE: Healthcare Cost and Utilization Project Nationwide Inpatient Sample, 1994 Sample, , 1996 Sample, , 1998 Sample, , 2000 increase in hospitalizations for urinary incontinence due to fistulae (Table 15 ). This rate remained steady at 6.7 to 7.6 per 100,000 women between 1994 and 2000. However, although the rate is low, 7,000 hospitalizations for incontinence due to fistulae are estimated to occur each year nationwide, suggesting that further attention should be paid to prevention.
Outpatient Care Outpatient and Emergency Room Visits
While the rate of hospitalizations for incontinence surgeries decreased, outpatient visits for urinary incontinence more than doubled between 1992 and 2000 for women both with and without Medicare. Physician visits with urinary incontinence listed as any reason for the visit climbed from 845 per 100,000 women in 1992 to 1,845 per 100,000 in 2000, according to National Ambulatory Medical Care Survey (NAMCS) data (Table 16 ). Similarly, visits for which incontinence was the primary reason rose from 468 per 100,000 in 1992 to 1,107 per 100,000 in 2000. Office visits for incontinence by women ages 65 and over enrolled in Medicare rose from 1,371 per 100,000 in 1992 to 2,937 per 100,000 in 1998 (Table 17) . While the reason for this increase is unknown, at least two potentially related events occurred. AHRQ published its first clinical practice guidelines on urinary incontinence in 1992; these were widely promulgated and may have led to more visits. Second, several new anticholinergic medications for urge incontinence were approved during the late 1990s. The releases of the first new medications for incontinence in several decades were accompanied by major directto-consumer advertising campaigns. Thus visits may also have increased because more women became aware that treatment existed. However, this illustrates the difficulty in comparing rates across data sets. Table  3 shows that 38% of elderly women report having UI. Table 8 suggests that 40% of women with UI report seeing a physician. However, in 1998, only 3% of Medicare female beneficiaries had a physician visit for UI. Thus it would appear that people over-report seeing a doctor, UI is under-reported on billing data, or some combination of the two.
Not surprisingly, given the nonemergent nature of urinary incontinence, few women seek emergency room care for it. Only 11 per 100,000 women ages 65 and older enrolled in Medicare were evaluated in emergency room settings for this disorder in 1998.
Ambulatory Surgery
Ambulatory surgical center visits for female urinary incontinence also increased, particularly in women younger than 65. Among those with commercial health insurance, the rate of such visits increased from 15 per 100,000 in 1994 to 34 per 100,000 in 2000 (Table 18 ). A steady increase was seen in middle-aged women; the rate of ambulatory surgical visits by women 55 to 64 years of age increased from 61 per 100,000 in 1996 to 69 per 100,000 in 1998 and 77 per 100,000 in 2000. Older women also had more ambulatory surgical visits; the rate of such visits by women 65 and older enrolled in Medicare in 1998 was 142 per 100,000 (Table 19 ). The increased rate of ambulatory surgery is probably due to the wider use of endoscopic injections such as collagen to treat urinary incontinence in women. Collagen for this purpose was not available in 1992, but by 1995 
*Collagen injection introduced in 1993.
SOURCE:
Centers for Medicare and Medicaid Services, 1992 Services, , 1995 Services, , 1998 3,704 per 100,000 women enrolled in Medicare were undergoing this therapy. This rate has since plateaued (Table 14 and Figure 6 ).
Nursing Home Care
Incontinence is particularly a problem in the frail elderly and is exacerbated by dementia, functional limitations, and comorbid conditions. In the United States, identification of incontinence by the Minimum Data Set (developed by the US Health Care Financing Administration) within 14 days of nursing home admission is mandated (18) .
According to data collected by the National Nursing Home Survey (NNHS), the rate of women in nursing homes with an admitting or current diagnosis of urinary incontinence has remained fairly stable; the most recent estimate (for 1999) is 1,366 per 100,000. The rate is very similar across age groups of nursing home residents (Table 20) . Few female nursing home residents with urinary incontinence have indwelling urethral catheters or ostomies (9,495 per 100,000 in 1999) (Table 21) ; however, fully half require another person's assistance when using the toilet.
Urinary incontinence is regarded as an important risk factor for nursing home admission. Research has indicated that a significant proportion of those admitted to nursing homes are incontinent of urine at the time of their admission (19, 20) . After adjustment for age, cohort factors, and comorbid conditions, Thom found that the relative risk of admission to a nursing home is two times greater for incontinent women (21) .
The sharp divergence of the NNHS data from published studies on the prevalence of incontinence in nursing homes compels us to pay particular attention to the method of collecting information on incontinence in nursing home residents. According to NNHS data, only 1% to 2% of nursing home patients have an admitting or current diagnosis of urinary incontinence, a finding that highlights the limitations of using administrative data to study the prevalence of incontinence. When queries about bladder function are expanded to include assistance needed from nursing home staff, a high prevalence of bladder dysfunction becomes apparent. Over half of all female nursing home residents are reported to have "difficulty controlling urine," and over half need assistance in using the toilet (Table 22) . Thus, when interpreting incontinence prevalence rates, great care must be taken to clarify the definition of incontinence used.
ECONOMIC IMPACT
Medical expenditures for urinary incontinence among female Medicare beneficiaries (65 years of age and older) nearly doubled between 1992 and 1998 from $128.1 million to $234.4 million, primarily due to increased aggregate costs for physician office visits and ambulatory surgery (Table 23) . At the same time, inpatient costs increased only modestly between 1992 and 1995, then decreased slightly in 1998 ( Figure 7) . Table 24 illustrates that, as with Medicare, during the 1990s expenditures in the general population shifted to the outpatient setting. This change in venue probably reflects the general shift of surgical procedures to the outpatient setting, as well as the advent of new procedures, such as periurethral collagen injections, which do not require hospital admission. In addition, the increase in awareness of incontinence and the marketing of new drugs for its treatment may have increased the number of office visits. While claims-based costs are substantial, others have projected the aggregate cost of UI to be even higher. In one estimation model that included women and men, the aggregate cost of urinary incontinence in the United States in 1995-including diagnostic testing, medical and surgical therapy, medications, routine care, hospitalization, skin irritation, related infections and falls, and other factors-was estimated to be $26.3 billion, almost one-fourth of which was borne by patients themselves as part of routine care (22) (Table 25) .
Using diagnostic algorithms, disease prevalence data, reimbursement costs, and sensitivity analyses, Survey, 1994 Survey, , 1996 Survey, , 1998 Survey, , 2000 1995 (Table 26 ). The largest cost category was routine care, which accounted for 70% of all costs.
In a multivariate analysis controlling for age, gender, work status, median household income, urban vs rural residence, medical and drug plan characteristics, and comorbid conditions, the presence of urinary incontinence was associated with more than twice the annual expenditures per person per year compared to those without this condition (Table  27 ).
The indirect costs for urinary incontinence are estimated by measurements of work lost (Tables 28  and 29) . Among all workers with urinary incontinence, 23% of women missed work, while only 8% of men did so. Average annual work absence for women totaled 28.7 hours for both inpatient (7.1 hours) and outpatient (21.6 hours) services. Although women and men had similar numbers of outpatient visits for urinary incontinence, average work loss associated with outpatient care was greater for women (Table   29) , probably because of the availability of outpatient procedures for women.
RECOMMENDATIONS
Classification and Coding
Existing databases allow researchers to describe trends in incontinence surgery and hospitalization more accurately than trends in outpatient visits or treatment in nursing homes. Urinary incontinence may be coded as stress incontinence, urge incontinence, mixed incontinence, intrinsic sphincter deficiency, frequency, nocturia, or other terms. Visits during which patients return for follow-up after treatment are also often coded as visits for incontinence, even if the symptom has resolved. While providers can be urged to code more diligently, administrative databases alone will never yield the degree of clinical accuracy needed to create a comprehensive picture of urinary incontinence and its impact on women 
Future Studies
Given the large number of women affected by urinary incontinence, future studies focusing on both prevention and treatment are vital. Longitudinal studies are needed to delineate the risk factors for urinary incontinence and fistulae in women in different age groups. Such long-term prospective cohort studies, as well as randomized trials, can help determine which factors are amenable to intervention and whether such intervention can change continence status. Welldesigned studies are needed to evaluate the effect of child-bearing practices on urinary incontinence and other pelvic floor disorders, particularly in younger women.
Many studies of urinary incontinence treatment have very narrow inclusion criteria and do not reflect the general population of incontinent women. More population-based studies are needed. In addition, the inclusion criteria should be broadened in future randomized trials, particularly those of pharmacologic agents, to make the trial results more relevant. Long-term follow-up studies are needed to improve understanding of the longevity of therapeutic effectiveness for incontinence, particularly in patients who have had surgery. 28.7 (14.9-42.5) a Individuals with an inpatient or outpatient claim for urinary incontinence and for whom absence data were collected. Work loss is based on reported absences contiguous to the admission and discharge dates of each hospitalization or the date of the outpatient visit. b Inpatient and outpatient include absences that start or stop the day before or after a visit. SOURCE: MarketScan, 1999. 
